Michal Štros

2.2k citations
36 papers · 1.9k indexed · h-index 21
Topics
DNA and Nucleic Acid Chemistry (14 papers)RNA and protein synthesis mechanisms (10 papers)Advanced Glycation End Products research (9 papers)
Partner nations
CzechiaFranceCanada

In The Last Decade

Michal Štros

36 papers receiving 1.9k citations

Peers

Michal Štros
Comparison fields: 5 of 96
  • Molecular Biology 1.3k
  • Clinical Biochemistry 624
  • Immunology 419
  • Oncology 302
  • Genetics 159
Replace Masashi Morita with:
Masashi Morita Japan
Michiteru Yoshida Japan
Sabine S. Lange United States
Osamu Kuge Japan
Patricie Burda Switzerland
Kim Milarski United States
Martin Hřebı́ček Czechia
Megan Bestwick United States
Makoto Hijikata Japan
Mitsushi Inomata Japan
Michal Štros relative to Masashi Morita Japan Masashi Morita's profile →
Citations per field
00.5×2.8×
Masashi Morita · 1×
Citations per year

Countries citing papers authored by Michal Štros

Since Specialization
Citations

This map shows the geographic impact of Michal Štros's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michal Štros with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michal Štros more than expected).

Fields of papers citing papers by Michal Štros

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michal Štros. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michal Štros. The network helps show where Michal Štros may publish in the future.

Co-authorship network of co-authors of Michal Štros

This figure shows the co-authorship network connecting the top 25 collaborators of Michal Štros. A scholar is included among the top collaborators of Michal Štros based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michal Štros. Michal Štros is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 27
2 16
3 19
4 59
5 493
6 33
7 229
8 33
9 162
10 43
11 50
12 33
13 5
14 38
15 15
16 129
17 23
18 3
19 10
20 11

About Michal Štros

Michal Štros is a scholar working on Clinical Biochemistry, Molecular Biology and Oncology, having authored 36 papers that have together received 1.9k indexed citations. Recurring topics across this work include DNA and Nucleic Acid Chemistry (14 papers), RNA and protein synthesis mechanisms (10 papers) and Advanced Glycation End Products research (9 papers). The work is most often cited by research in Clinical Biochemistry (624 citations), Immunology (419 citations) and Molecular Biology (1.3k citations). Michal Štros has collaborated with scholars based in Czechia, France and Canada. Frequent co-authors include Klaus D. Grasser, Dorte Launholt, Jitka Štokrová, Jean Thomas, Šárka Pospı́šilová, Alena Bačı́ková, Hajime Kageyama, Toshinori Ozaki, Akira Nakagawara and François Strauss. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026